Arguments for and against Germline Intervention: A Critical Review of Ronald Green’s Babies by Design

Download Edit this record How to cite View on PhilPapers
Abstract
It seems certain that one day we will allow the genetic technology which will enhance our offspring. A highly effective new tool, called CRISPR, which allows for carving out genes, is already being used to edit the genomes of animals. In July 2017, the FDA legalized that germline drugs for therapeutic purposes could be sold in the market. It is a high time, now, that we need engage in discussions about the ethics of germline intervention. To contribute to the discussion by showing our thought and to educate the public, we write this paper.
Categories
(categorize this paper)
PhilPapers/Archive ID
LEEAFA-2
Upload history
First archival date: 2017-08-15
Latest version: 2 (2019-08-05)
View other versions
Added to PP index
2017-08-15

Total views
300 ( #16,445 of 53,635 )

Recent downloads (6 months)
53 ( #11,768 of 53,635 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.